Placental transfer of the insulin analog glargine in the ex vivo perfused placental cotyledon model
- PMID: 21226564
- DOI: 10.3109/07435800.2010.534752
Placental transfer of the insulin analog glargine in the ex vivo perfused placental cotyledon model
Erratum in
- Endocr Res. 2011;36(2):91
Abstract
Objective: The aim was to characterize the transfer of the insulin analog glargine across the placenta using the placental perfusion model.
Methods: Placentas were obtained and selected cotyledons were cannulated and dually perfused. Glargine, 50 mU/L (n = 2) and 200 mU/L (n = 1), and a reference marker, antipyrine (50 μg/mL), were added to the maternal circulation. Samples were taken from the maternal and fetal compartments.
Results: Glargine was not detected in the fetal compartment. In the maternal compartment, the steady state concentration was 50% lower than the starting concentration.
Conclusions: Glargine probably does not cross the human placenta. Reduced maternal steady state concentrations may suggest insulin uptake by the placenta.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials